Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
42.16
+1.25 (3.06%)
At close: Nov 11, 2026, 4:00 PM EST
42.14
-0.02 (-0.05%)
Pre-market: Nov 12, 2026, 9:00 AM EST
Medline Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 2,321 | 1,939 | 199 | 1,556 | - |
Trading Asset Securities | 13 | 36 | 79 | 135 | - |
Cash & Short-Term Investments | 3,621 | 1,975 | 278 | 1,691 | - |
Cash Growth | 263.19% | 610.43% | -83.56% | - | - |
Receivables | 3,797 | 3,533 | 3,219 | 2,960 | - |
Inventory | 4,806 | 4,769 | 4,456 | 3,813 | - |
Restricted Cash | 2 | 3 | 51 | 29 | - |
Other Current Assets | 427 | 399 | 268 | 316 | - |
Total Current Assets | 12,653 | 10,679 | 8,272 | 8,809 | - |
Property, Plant & Equipment | 4,728 | 5,210 | 4,979 | 4,797 | - |
Long-Term Investments | - | - | 48 | 86 | - |
Goodwill | 8,073 | 8,079 | 8,065 | 7,532 | - |
Other Intangible Assets | 13,377 | 13,893 | 14,559 | 14,788 | - |
Long-Term Deferred Tax Assets | 833 | 583 | - | - | - |
Other Long-Term Assets | 514 | 40 | 55 | 110 | - |
Total Assets | 40,178 | 38,484 | 35,978 | 36,122 | - |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 1,209 | 961 | 869 | 696 | - |
Accrued Expenses | 1,306 | 960 | 941 | 856 | - |
Short-Term Debt | 1 | 1 | 2 | 2 | - |
Current Portion of Long-Term Debt | 28 | 76 | 76 | 73 | - |
Current Portion of Leases | 68 | 66 | 76 | 47 | - |
Current Income Taxes Payable | - | 24 | 4 | 9 | - |
Other Current Liabilities | 517 | 402 | 472 | 448 | - |
Total Current Liabilities | 3,129 | 2,490 | 2,440 | 2,131 | - |
Long-Term Debt | 12,551 | 12,484 | 16,416 | 16,446 | - |
Long-Term Leases | - | 386 | 329 | 264 | - |
Pension & Post-Retirement Benefits | - | 49 | 42 | 33 | - |
Other Long-Term Liabilities | 5,112 | 3,789 | 593 | 504 | - |
Total Liabilities | 20,792 | 19,198 | 19,820 | 19,378 | - |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | - | - | 16,147 | 16,556 | - |
Additional Paid-In Capital | 11,428 | 10,717 | - | - | - |
Retained Earnings | 377 | -7 | - | - | - |
Comprehensive Income & Other | -4 | 27 | 11 | 188 | - |
Total Common Equity | 11,801 | 10,737 | 16,158 | 16,744 | - |
Minority Interest | 7,585 | 8,549 | - | - | - |
Shareholders' Equity | 19,386 | 19,286 | 16,158 | 16,744 | - |
Total Liabilities & Equity | 40,178 | 38,484 | 35,978 | 36,122 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 12,648 | 13,013 | 16,899 | 16,832 | - |
Net Cash (Debt) | -9,027 | -11,038 | -16,621 | -15,141 | - |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -10.27 | -13.63 | -0.95 | -0.87 | - |
Filing Date Shares Outstanding | 878.66 | 811.65 | 17,467 | 17,500 | - |
Total Common Shares Outstanding | 879 | 812 | 17,467 | 17,500 | - |
Working Capital | 9,524 | 8,189 | 5,832 | 6,678 | - |
Book Value Per Share | 13.43 | 13.22 | 0.93 | 0.96 | - |
Tangible Book Value | -9,649 | -11,235 | -6,466 | -5,576 | - |
Tangible Book Value Per Share | -10.98 | -13.84 | -0.37 | -0.32 | - |
Land | - | 586 | 599 | 590 | - |
Buildings | - | 2,974 | 2,879 | 2,805 | - |
Machinery | - | 1,700 | 1,477 | 1,309 | - |
Construction In Progress | - | 466 | 316 | 164 | - |
Leasehold Improvements | - | 60 | 11 | 36 | - |